The palette of Cashline Group’s current investments is extremely colourful. It spreads from agriculture through the financial services to the most innovative sectors of the industry. Cashline participates in the formulation of the strategy of these companies, as well as, in solving occasional daily operative tasks if required.
Biotech & Healthcare
investments
PepTC Vaccines Ltd. (USA)
PepTC Vaccines’ PolyPEPI-SCoV-2 investigative vaccine is designed to elicit long-term T cell immunity in contrast to most of the vaccine candidates being developed with antibodies. It consists of 10 different, 30-amino acid long synthetic peptides. In silico preclinical testing of the PolyPEPI-SCoV-2 vaccine with diverse ethnic groups of approximately 16,000 HLA genotyped subjects from a U.S. bone marrow donor database resulted in an equally high proportion of subjects showing both CD8+ and CD4+ T cell responses in each ethnic group.
Go to websitePulseNmore Ltd. (ISR)
PulseNmore is pioneering the field of home-based telehealth ultrasound solutions which can be set up with a smartphone application and a platform with a cradle and a disposable part. The technological breakthrough has for the first time enabled non-trained consumers to use portable ultrasound at home for multiple applications at an affordable price, with or without the supervision of a doctor. The product is currently used in obstetric (pregnant women) and congestive heart failure (CHF) patients; however, they are continuously seeking for new fields of application.
Go to websiteTreos Bio Ltd. (USA)
A group of biomedical and bioinformatics science experts in vaccine development founded TREOS to create a digital cancer vaccine technology for developing precision vaccines tailored to patients’ genetics. Their mission is to deliver safe and broadly effective cancer immunotherapies that are developed fast and at low cost.
Go to websiteRedDress Ltd. (ISR)
Founded in 2009 by Dr. Igal Kushnir MD and Alon Kushnir with the goal of developing more effective, natural, and economically viable treatments. An experienced team of medical experts and business leaders is committed to delivering advanced, cost-effective chronic wound solutions that improve life for both patients and medical professionals. Their unprecedented, proprietary and patented technology delivers the healing power of advanced biological products at an economically viable price, healing wounds effectively. Their ActiGraft product transforms the patient’s blood into an autologous clot that promotes the body’s natural wound healing processes.
Go to websiteCardiacSense (ISR)
CardiacSense is an Israeli company founded in 2012 by Eldad Shemesh, a veteran of the Israeli Air Force. The company’s expert team combines years of clinical, technical and business experience to provide an affordable solution for hundreds of millions of people worldwide suffering from hypertension. CardiacSense has developed a unique, state-of-the-art watch with all the necessary sensor technology for continuous monitoring of heart arrhythmias and blood pressure. Furthermore, the CardiacSense watch enables big data analysis and AI backed healthcare since it provides the continuous monitoring of vital signs.
Go to websiteElectronRx (UK)
ElectronRx is a digital healthcare company, leading disruptive development in remote diagnostics and non-invasive pain management technology, through which they aspires to become part of the digital therapeutics industry. Their overall purpose is to create a new class of medicine, highly tailored to the conditions of each individual, with no side effects for the patient; at the same time, offering healthcare professionals new medical insights from the vast amount of high-quality data generated. By developing digital healthcare technologies, harnessing Artificial Intelligence and Machine Learning, signal processing and connected devices to enable early detection, monitoring of existing conditions and pain management.
Tovább a weboldalra